Announcements
- Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
- Immuron CEO Steven Lydeamore to present at Peak Sky High
- Immuron Board Changes
- Immuron Limited to Present at the Emerging Growth Conference
- Immuron Director Resignation
- Immuron to host Live Virtual Event
- Immuron Travelan® sales continued strong growth
- Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
- Immuron Presentation Australian Biologics Festival 2024
- Immuron achieves record Travelan® sales
More ▼
Key statistics
As of last trade, Immuron Ltd (ANWA:MUN) traded at 2.18, 54.61% above the 52 week low of 1.41 set on Nov 14, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.18 |
---|---|
High | 2.18 |
Low | 2.18 |
Bid | 2.02 |
Offer | 2.10 |
Previous close | 2.18 |
Average volume | 88.89 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jun 07 2024 07:10 BST.
More ▼